Bayer unveils vision to transform prostate cancer care ahead of ESMO 2025
Redefining prostate cancer diagnosis and care Bayer has outlined an ambitious new vision for transforming prostate cancer care globally, emphasizing innovation in imaging, early detection, and patient-centered treatment strategies. Presented ahead of the European Society for Medical Oncology (ESMO) 2025 Congress, the initiative reflects Bayer’s commitment to redefining standards in oncology and radiology through scientific […]



